Asciminib (ASC) demonstrates continued improvement in patient-reported outcomes (PROs) vs investigator-selected tyrosine kinase inhibitors (IS-TKIs) in newly diagnosed chronic myeloid leukemia (CML): ...
On 27 February 2025, Ramsay Générale de Santé acknowledged the announcement of its Australian reference shareholder Ramsay Health Care Limited regarding the review of its strategic options associated ...
Global license provides American Regent, a wholly owned subsidiary of Daiichi Sankyo, with rights to commercialize Synoglide™ in the veterinary market in most countries of the world. Allegro retains ...
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly ...
Le 27 février 2025, Ramsay Générale de Santé prenait acte de l’annonce de son actionnaire de référence australien Ramsay Health Care Limited relative à la revue de ses options stratégiques concernant ...
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback